-

Shareholder Alert: Robbins LLP Is Investigating Whether Officers and Directors of Brookdale Senior Living Inc. (BKD) Misled Shareholders

SAN DIEGO & BRENTWOOD, Tenn.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that it is investigating certain officers and directors of Brookdale Senior Living Inc. (NYSE: BKD) for breaches of their fiduciary duties, unjust enrichment, waste of corporate assets, and gross mismanagement. Brookdale Senior Living owns and operates senior living communities in the United States.

If you suffered a loss due to Brookdale Senior Livings' misconduct, click here.

Brookdale Senior Living Inc. (BKD) Understaffed Senior Living Centers

Between August 2016 and April 2020, Brookdale failed to disclose and made misleading statements regarding the Company’s business, operational, and legal profiles. Over the years, Brookdale repeatedly affirmed its operating efficiency based on proprietary software that determined daily staffing needs at its facilities. However, Brookdale underestimated the data inputs entered into the software in an effort to meet certain financial performance targets, which resulted in daily staffing at its facilities to come in below levels necessary to meet resident need. As a result, Brookdale failed to provide proper care and breached resident contracts. Residents have filed class actions against Brookdale for "chronically insufficient staffing" at its facilities that "routinely" failed to sufficiently service the needs of its residents, and intentionally underestimating data inputs to meet financial benchmarks. On April 30, 2020, the Nashville Business Journal reported on these class actions and exposed "lucrative bonus and incentive programs tied to meeting or exceeding Brookdale's financial performance targets" to entice employees to "stay at or below Brookdale's limits for staffing expenses." On this news, Brookdale's share price fell over 15% over two trading sessions to close at $3.12 per share. Brookdale is currently the subject of a securities fraud class action, which can cause further harm to the Company.

Brookdale Senior Living Inc. (BKD) Shareholders Have Legal Options.

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Brookdale Senior Living Inc. settles or to receive free alerts about companies engaged in wrongdoing, signup for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom